Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline + RP for Pathological Gambling with Alcohol Abuse
NCT00249431Phase 2Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2001
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in gambling disorder (GD), alcohol use disorder (AUD) and alcohol dependence comparing Placebo + RP with Sertraline + RP (2 arms). Primary endpoint: Decreased gambling behavior at 10 weeks. Started Dec 2001; status: terminated.
02
Drugs
sertraline
03
Conditions
gambling disorder (GD)alcohol use disorder (AUD)alcohol dependence
Beyond the preview
Go deeper on NCT00249431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249431.